Identification of a metabolic reprogramming-associated risk model related to prognosis, immune microenvironment, and immunotherapy of stomach adenocarcinoma

HIGHLIGHTS

• who: Yan Zhao et al. from the Department of Gastrointestinal Surgery, Affiliated Hospital of Jiangnan University, Wuxi, China have published the paper: Identification of a Metabolic Reprogramming-Associated Risk Model Related to Prognosis, Immune Microenvironment, and Immunotherapy of Stomach Adenocarcinoma, in the Journal: Journal of Oncology 0.00045 of 21/09/2022
• what: In this study, statistical analysis was carried out using the SPSS and R software (version 3.5.1).
• how: The mutation data were examined using the maftool package and the mutations were stratified according to the variant effect predictor. Although . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.